UnknownPhase 2NCT03813056

Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy

Studying Corneal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Michael D. Straiko, MD
Principal Investigator
Michael D Straiko, M.D.
Devers Eye Institute
Intervention
Glanatec(drug)
Enrollment
72 enrolled
Eligibility
30-99 years · All sexes
Timeline
20192025

Study locations (1)

Collaborators

Lions VisionGift Research · Eye Bank Association of America

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03813056 on ClinicalTrials.gov

Other trials for Corneal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Corneal dystrophy

← Back to all trials